ArticleAnalytical chemistry2026
Comparative Real-Time Kinetics of Ligand-Receptor Interactions Using Immobilization-Based Sensing Readouts.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Interactions between receptor tyrosine kinases and their specific growth factor ligands are crucial for cell signaling. Although much research has focused on these processes, quantitative attention to their earliest kinetics has been limited. Here, we used two immobilization-based sensing methods, biolayer interferometry (BLI) and surface plasmon resonance (SPR), to analyze the real-time binding kinetics of three high-affinity ligands with the full extracellular domain of various epidermal growth factor receptor (EGFR) isoforms. We observed that BLI measurements show both fast and slow dissociation phases, regardless of the EGFR isoform. SPR experiments, despite using a different detection readout, confirm the existence of two binding substates, indicating that this is a common feature of ligand-EGFR interactions. Furthermore, our data systematically demonstrate that the type of immobilization-based sensing technique influences not only the magnitude of kinetic and affinity parameters but also the relative interactions among different ligands and EGFR isoforms. Using these methods, we also found that glycan side chains at position N151 within the canonical ligand-binding site do not affect overall interactions with the three common high-affinity growth factors. Finally, we show that an extensively deglycosylated EGFR isoform binds all tested ligands with significantly lower affinity. Our approach could be applied to other ligand-receptor systems to directly evaluate how specific posttranslational modifications impact their interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.